PlainPharmaWatch

CMS Open Payments · Program Year 2024

Immunitybio, Inc.

Immunitybio, Inc. reported $67,816.03 in payments to 1,612 physicians and teaching hospitals across 1,612 transactions.

See the rankings → How this is sourced
$67.8K
Total payments
1,612
Transactions
1,612
Recipients
#1276
of 1,925 companies

Immunitybio, Inc. reported $67,816.03 in payments to 1,612 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1276 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $42.07 per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Immunitybio, Inc. pairs below-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#1276
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
3
payment categories

How Immunitybio, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Immunitybio, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$67,816 34th percentile higher than 34% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). This entry sits in this band. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Immunitybio, Inc.

Immunitybio, Inc. ranks #1276 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $67,816.03 across 1,612 transactions to 1,612 physicians and teaching hospitals - $42.07 per transaction and $42.07 per recipient on average.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $44.0K, accounting for 64.9% of the company's reported total and 1,599 transactions.

General Payment Breakdown by Type

Immunitybio, Inc. made 3 types of general payments. "Food and Beverage" is the largest category at $44.0K, 64.9% of the company's reported total.

How Immunitybio, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$44.0K2. Honoraria$17.6K3. Consulting Fee$6.2K
Payment Type Amount Transactions
Food and Beverage $44.0K 1,599
Honoraria $17.6K 11
Consulting Fee $6.2K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $13,187.01 (19.4%) of $67,816.03 in this company's General Payments records across 1,282 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Immunitybio, Inc.

The five named recipients with the highest reported General Payments from this company

Jason Matthew Hafron$3.9KGary Steinberg$2.4KPeter O Donnell$2.4KJoshua Meeks$2.4KArpeet Satish Shah$2.1K
  1. 1

    Jason Matthew Hafron

    $3,864.40 across 5 reported transactions

  2. 2

    Gary Steinberg

    $2,400.00 across 1 reported transactions

  3. 3

    Peter O Donnell

    $2,400.00 across 1 reported transactions

  4. 4

    Joshua Meeks

    $2,400.00 across 1 reported transactions

  5. 5

    Arpeet Satish Shah

    $2,122.61 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $42.07. Average per recipient: $42.07.

Total Amount

$67,816.03

Avg per Transaction

$42.07

Avg per Recipient

$42.07

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Immunitybio, Inc. Share

0.0%

#1276 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Immunitybio, Inc.

Shimadzu Precision Instruments, Inc.

$67.9K 21 recipients

MIM Software Inc.

$67.1K 50 recipients

Icometrix NV

$67.0K 26 recipients

RedHill Biopharma Inc.

$68.8K 1,502 recipients

Momentis Surgical Inc.

$66.7K 21 recipients

Nexus CMF, LLC

$69.0K 339 recipients

Frequently Asked Questions

How much did Immunitybio, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $67,816.03 from Immunitybio, Inc. to physicians and hospitals across 1,612 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Immunitybio, Inc.? ▾
Averaging $42.07 per recipient, Immunitybio, Inc.'s 2024 payments reached 1,612 physicians and teaching hospitals.
What types of payments did Immunitybio, Inc. make? ▾
Immunitybio, Inc. made 3 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Food and Beverage" at $44.0K, representing 64.9% of the company's reported total.
How does Immunitybio, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Immunitybio, Inc. sits at #1276 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Immunitybio, Inc.? ▾
The average transaction from Immunitybio, Inc. was $42.07 in 2024. The company made 1,612 total transactions to 1,612 recipients.
Where does the payment data for Immunitybio, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Immunitybio, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.